(Q44950219)

7 December 2017

title

A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: An RTOG study (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

9 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

9 December 2022

author name string

S. Order

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

T. Pajak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

S. Leibel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

S. Asbell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

P. Leichner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

D. Ettinger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

G. Stillwagon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

J. Herpst

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

T. Haulk

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

K. Kopher

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850722

9 December 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

full work available at URL

7 December 2017

https://api.elsevier.com/content/article/PII:0360301691901916?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

https://api.elsevier.com/content/article/PII:0360301691901916?httpAccept=text/plain

9 December 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

International Journal of Radiation Oncology Biology Physics

9 December 2022

published in

1 reference

7 December 2017

volume

20

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

953-963

1 reference

Computed tomography assisted volumetric analysis of primary liver tumor as a measure of response to therapy

7 December 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Primary hepatocellular cancer--present results and future prospects.

9 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival

9 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma. A phase II study

9 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Nonparametric Estimation from Incomplete Observations

9 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Evaluation of survival data and two new rank order statistics arising in its consideration

9 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

9 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Intra-arterial cis-platinum infusion with sodium thiosulfate protection and angiotensin ii induced hypertension for treatment of hepatocellular carcinoma

9 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study

9 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver

9 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Hepatocellular carcinoma. A retrospective analysis of treatments to manage disease confined to the liver

9 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients.

9 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Mouse/human chimeric antibodies to a tumor-associated antigen: biologic activity of the four human IgG subclasses

9 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer

9 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection

9 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

Polyclonal 90Yttrium labeled antiferritin for refractory Hodgkin's disease.

9 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90191-6

9 December 2022

Identifiers

1 reference

7 December 2017

1 reference